Veeva CEO: Reinvention Makes a Great Company

Veeva Systems offers pharmaceutical and other highly regulated chemical manufacturers a cloud-based solution to make their employees and companies be more efficient and in regulatory compliance.

$650 Million Settlement Reached in Pradaxa Lawsuit

Boehringer Ingelheim Pharmaceuticals this week agreed to a settlement in the multi-district litigation over the drug Pradaxa. The company has agreed to pay $650 million to settle the lawsuits. Much of that money will be used to compensate patients who…

Multiple Sclerosis Drug Delayed by FDA

Biogen Idec Inc. has stated that the U.S. Food and Drug Administration extended the review process its multiple sclerosis drug called Plegridy by three months to evaluate the application, though the FDA didn’t request any further studies. Biogen had planned…

New Painkiller Zohydro: What Parents And Patients Need To Know

Painkiller junkies who’ve diligently done research are anxiously awaiting the arrival of a pill called Zohydro. Meanwhile, a well-meaning coalition of health professionals is also anticipating – the imminent demise of such existing abusers and legitimate patients alike. They are…

FDA Implements Pilot Program For Fast-Track Drug Importation

The U.S. Food and Drug Administration (FDA) today announced that it has begun its two-year Secure Supply Chain Pilot Program. The program is meant to streamline some drug importation for select companies so that the FDA can focus its resources…

Depression Drug Vyvanse Sent Back To Drawing Board

The pharmaceutical group Shire has decided to stop developing the drug Vyvanse for use to treat depression. The Amphetamine-based Vyvanse is a popular ADHD drug, having made over $1.2 billion dollars for related therapy last year. However, Shire was hoping…

Johnson & Johnson to Pay $2.2 Billion Over Risperdal Claims

The U.S. Department of Justice and the U.S. Food and Drug Administration (FDA) today announced that Janssen Pharmaceuticals has plead guilty over the misbranding of the drug Risperdal. Janssen and its company, Johnson & Johnson, will pay a total of…

Merck Job Cuts On the Rise, Cuts Could Prove Beneficial

For months, the struggling New Jersey- based pharmaceutical conglomerate has been struggling, and the numbers they’ve been producing have only made their financial woes more evident. But, yesterday the company set a new plan of action in motion. Merck &…

Purdue, Maker of OxyContin, Keeps a List of Bad Docs

Earlier this year, the FDA made headlines when it prevented pharmaceutical giant Purdue Pharma from continuing to produce generic and crushable versions of the popular opioid OxyContin. The New York Times took note that the company had chosen the opportune…

Cholesterol Drug Tredaptive Pulled Worldwide

Less than one month ago, Merck, a major U.S. pharmaceutical company, announced that its cholesterol drug Tredaptive failed a major clinical trial. The drug is meant to improve heart health by increasing levels of “good” cholesterol, but the trial found…